Clarifying Bacne

Description

This bacne spray from Dermalogica, part of the Clear Start line, is designed to clarify and rebalance the skin. The product is presented in a 6 US FL OZ (177 mL) container, providing an effective solution for addressing back acne.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer one to three times daily. It is advisable to initiate treatment with one application per day to minimize the risk of excessive drying of the skin. Based on the patient's response, the frequency may be gradually increased to two or three times daily, or as directed by a physician.

In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day. When administering the product, the spray should be held approximately 18 inches (one and a half feet) away from the body. The mist should be applied to clean, dry skin, and it is important to allow the product to absorb into the skin for 30 to 60 seconds before proceeding with any additional steps in the treatment regimen.

Contraindications

Use is contraindicated in the following situations:

Contact with the eyes should be avoided; in the event of contact, the affected area must be flushed thoroughly with water. If irritation develops during use, the product should be discontinued immediately. Inhalation of the product is also contraindicated.

Warnings and Precautions

For external use only. It is imperative that this product is not applied in or near the eyes. In the event of contact with the eyes, it is essential to flush thoroughly with water to mitigate any potential irritation.

Healthcare professionals should advise patients to discontinue use if any irritation develops. The likelihood of skin irritation and dryness may increase if this product is used concurrently with other topical acne medications. Therefore, it is recommended that only one topical acne medication be utilized at a time to minimize the risk of adverse effects.

Inhalation of the product should be strictly avoided. It is crucial to keep this product out of reach of children to prevent accidental ingestion. In the case of swallowing, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. It is contraindicated for use in or near the eyes; in the event of contact, it is essential to flush the area thoroughly with water. Should irritation develop during use, patients are advised to discontinue use immediately.

When utilizing this product, the likelihood of skin irritation and dryness may increase if another topical acne medication is used concurrently. Therefore, it is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation. Additionally, patients should avoid inhalation of the product.

In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center without delay.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the products is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Clarifying Bacne (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Clarifying Bacne Spray in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this product to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable in this population, given the lack of established guidelines for geriatric use.

Pregnancy

The safety of this product during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Pregnant women should avoid using this product unless directed by a healthcare provider. It is essential for women of childbearing potential to consult a healthcare professional before using this product if they are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding. However, as with any medication, it is advisable to monitor breastfed infants for any potential adverse effects.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed about the importance of avoiding contact with the eyes. If contact occurs, they should flush the eyes thoroughly with water. Additionally, if any irritation develops while using the medication, patients are advised to discontinue use and consult their healthcare provider.

It is important to discuss the potential for skin irritation and dryness, particularly if patients are using another topical acne medication concurrently. Patients should be instructed to use only one topical acne medication at a time to minimize the risk of irritation.

Lastly, healthcare providers should emphasize that the medication should not be inhaled, and patients should be made aware of this precaution to ensure safe usage.

Storage and Handling

The product is supplied in a pressurized container. It is essential to store the product at temperatures not exceeding 120°F to maintain its integrity and effectiveness. Due to the pressurized nature of the contents, it is critical to avoid puncturing or incinerating the can to prevent potential hazards. Proper handling and storage conditions are vital to ensure safety and efficacy.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer covering the entire affected area one to three times daily. To minimize the risk of excessive skin drying, it is advised to begin with one application daily, gradually increasing to two or three times daily as necessary or as directed by a healthcare professional. Should patients experience bothersome dryness or peeling, they should reduce the frequency of application to once a day or every other day.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Clarifying Bacne, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)